Trial Profile
Comparison of olanzapine versus fosaprepitant when given in combination with palonosetron and dexamethasone in preventing nausea and vomiting in highly emetogenic chemotherapy (HEC) and radiation therapy receiving patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jun 2015
Price :
$35
*
At a glance
- Drugs Fosaprepitant (Primary) ; Cisplatin; Dexamethasone; Olanzapine; Palonosetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 18 Jun 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.